|
1
|
Beal AL and Cerra FB: Multiple organ
failure syndrome in the 1990s. Systemic inflammatory response and
organ dysfunction. JAMA. 271:226–233. 1994. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Bone RC, Balk RA, Cerra FB, Dellinger RP,
Fein AM, Knaus WA, Schein RM and Sibbald WJ: ACCP/SCCM Consensus
Conference Committee: Definitions for sepsis and organ failure and
guidelines for the use of innovative therapies in sepsis. The
ACCP/SCCM consensus conference committee. American college of chest
Physicians/Society of critical care medicine. 1992. Chest.
136(Suppl 5): e282009.
|
|
3
|
Wang Y: Multiple organs dysfunction
syndrome. Emergency Medicine. 6:Higher Education Press. (Beijing,
China). 162–168. 2006.
|
|
4
|
Abraham E, Wunderink R, Silverman H, Perl
TM, Nasraway S, Levy H, Bone R, Wenzel RP, Balk R, Allred R, et al:
Efficacy and safety of monoclonal antibody to human tumor necrosis
factor alpha in patients with sepsis syndrome. A randomized,
controlled, double-blind, multicenter clinical trial. TNF-alpha MAb
Sepsis Study Group. JAMA. 273:934–941. 1995. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Sakaguchi S, Sakaguchi N, Asano M, Itoh M
and Toda M: Immunologic self-tolerance maintained by activated T
cells expressing IL-2 receptor alpha-chains (CD25). Breakdown of a
single mechanism of self-tolerance causes various autoimmune
diseases. J Immunol. 155:1151–1164. 1995.PubMed/NCBI
|
|
6
|
Gallimore A and Sakaguchi S: Regulation of
tumour immunity by CD25+ T cells. Immunology. 107:5–9. 2002.
View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Shevach EM: Regulatory T cells in
autoimmmunity*. Annu Rev Immunol. 18:423–449. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Suvas S, Azkur AK, Kim BS, Kumaraguru U
and Rouse BT: CD4+CD25+ regulatory T cells control the severity of
viral immunoinflammatory lesions. J Immunol. 172:4123–4132. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Wood KJ and Sakaguchi S: Regulatory T
cells in transplantation tolerance. Nat Rev Immunol. 3:199–210.
2003. View
Article : Google Scholar : PubMed/NCBI
|
|
10
|
Mottet C, Uhlig HH and Powrie F: Cutting
edge: Cure of colitis by CD4+CD25+ regulatory T cells. J Immunol.
170:3939–3943. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Ziegler SF: FOXP3: Not just for regulatory
T cells anymore. Eur J Immunol. 37:21–23. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Mahnke K, Schönfeld K, Fondel S, Ring S,
Karakhanova S, Wiedemeyer K, Bedke T, Johnson TS, Storn V,
Schallenberg S and Enk AH: Depletion of CD4+CD25+ human regulatory
T cells in vivo: Kinetics of treg depletion and alterations in
immune functions in vivo and in vitro. Int J Cancer. 120:2723–2733.
2007. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Cao D, Malmström V, Baecher-Allan C,
Hafler D, Klareskog L and Trollmo C: Isolation and functional
characterization of regulatory CD25brightCD4+ T cells from the
target organ of patients with rheumatoid arthritis. Eur J Immunol.
33:215–223. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Aikawa N: Cytokine storm in the
pathogenesis of multiple organ dysfunction syndrome associated with
surgical insults. Nihon Geka Gakkai Zasshi. 97:771–777. 1996.(In
Japanese). PubMed/NCBI
|
|
15
|
Ohlsson K, Björk P, Bergenfeldt M, Hageman
R and Thompson RC: Interleukin-1 receptor antagonist reduces
mortality from endotoxin shock. Nature. 348:550–552. 1990.
View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Marshall JC, Cook DJ, Christou NV, Bernard
GR and Sibbald Sprung WJ: Multiple organ dysfunction score: A
reliable descriptor of a complex clinical outcome. Crit Care Med.
23:1638–1652. 1995. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Liu W, Putnam AL, Xu-Yu Z, Szot GL, Lee
MR, Zhu S, Gottlieb PA, Kapranov P, Gingeras TR, de St Groth
Fazekas B, et al: CD127 expression inversely correlates with FoxP3
and suppressive function of human CD4+ T reg cells. J Exp Med.
203:1701–1711. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Marshall JC: Inflammation, coagulopathy,
and the pathogenesis of multiple organ dysfunction syndrome. Crit
Care Med. 29(Suppl 7): S99–S106. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Yi L: Effects of gene types on
proinflammatory cytokines and anti-inflammatory cytokines in
patients with multiple organ dysfunction syndrome. Zhong Guo Wei
Zhong Bing Ji Jiu Yi. 15:962003.
|
|
20
|
Sakaguchi S, Ono M, Setoguchi R, Yagi H,
Hori S, Fehervari Z, Shimizu J, Takahashi T and Nomura T: Foxp3+
CD25+ CD4+ natural regulatory T cells in dominant self-tolerance
and autoimmune disease. Immunol Rev. 212:8–27. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Sakaguchi S, Setoguchi R, Yagi H and
Nomura T: Naturally arising Foxp3-expressing CD25+CD4+ regulatory T
cells in self-tolerance and autoimmune disease. Curr Top Microbiol
Immunol. 305:51–66. 2006.PubMed/NCBI
|
|
22
|
Mansilla-Roselló A, Ferrón-Orihuela JA,
Ruiz-Cabello F, Garrote-Lara D, Delgado-Carrasco S and Tamayo-Pozo
F: Interleukin-1beta and ibuprofen effects on CD4/CD8 cells after
endotoxic challenge. J Surg Res. 65:82–86. 1996. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Hernberg M, Muhonen T, Turunen JP,
Hahka-Kemppinen M and Pyrhonen S: The CD4+/CD8+ ratio as a
prognostic factor in patients with metastatic melanoma receiving
chemoimmunotherapy. J Clin Oncol. 14:1690–1696. 1996.PubMed/NCBI
|
|
24
|
Hernberg M, Muhonen T and Pyrhönen S: Can
the CD4+/CD8+ ratio predict the outcome of interferon-alpha therapy
for renal cell carcinoma? Ann Oncol. 8:71–77. 1997. View Article : Google Scholar : PubMed/NCBI
|
